Data as of Q4 2025 (Dec 31, 2025)

Parkman Healthcare Partners LLC

โ€ขCIK: 1777015โ€ขFiling: Q4 2025

**Parkman Healthcare Partners LLC** manages $1.1B across a concentrated portfolio of 100 positions, exhibiting a clear focus on the healthcare sector. Top holdings include BSX at $47.7M and PODD at $40.0M, signaling significant conviction in specific healthcare value plays. The remaining top ten positions represent a substantial allocation, with the top five holdings accounting for over $190M of the fund's current assets. This structure suggests a deep, sector-specific research approach targeting established and growth-oriented healthcare names.

Total AUM
$1.1B
QoQ Performance
+15.3%
Positions
100
Top 10 Concentration
32.3%
Latest Filing
Q4 2025

Top Holdings Allocation

BSX4.5%
PODD3.8%
DC43.7%
SYK3.5%
CVS3.4%
MCK2.8%
KALV2.7%
MBX2.7%

๐Ÿ“ˆ Biggest Buys

DC4
DEXCOM INC
+242.3%
3.7% of portfolio
3M4
MASIMO CORP
NEW
2.5% of portfolio
EYPT
EYEPOINT INC
NEW
1.9% of portfolio
WAT
WATERS CORP
NEW
1.5% of portfolio
MTD
METTLER TOLEDO INTERNATIONAL
NEW
1.5% of portfolio

๐Ÿ“‰ Biggest Sells

BIIB
BIOGEN INC
-72.8%
0.6% of portfolio
ALNY
ALNYLAM PHARMACEUTICALS INC
-45.6%
1.8% of portfolio
TERN
TERNS PHARMACEUTICALS INC
-33.6%
2.4% of portfolio
CSTL
CASTLE BIOSCIENCES INC
-68.3%
0.6% of portfolio
DHR
DANAHER CORPORATION
-46.7%
1.3% of portfolio

Sector Breakdown

Other94.3%
Healthcare5.7%

๐Ÿšช Exited Positionssold since Q3 2025

NDQ
INVESCO QQQ TR
SOLD
$48.0M
UTH
UNITED THERAPEUTICS CORP DEL
SOLD
$9.2M
INCY
INCYTE CORP
SOLD
$8.5M
ASND
ASCENDIS PHARMA A/S
SOLD
$8.0M
LLY
ELI LILLY & CO
SOLD
$7.6M
+6 more exited positions

Changes from Q3 2025

NEW20 new positions
โ†‘23 increased
โ†“56 decreased

Historical Filings

Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023